Single and Multiple Dose Study of BIIB067 (Isis-SOD1Rx) in Adults With Amyotrophic Lateral Sclerosis (ALS)

Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Drug: BIIB067 (Isis-SOD1Rx);   Other: Placebo
Sponsors:   Biogen;   Ionis Pharmaceuticals, Inc.
Recruiting - verified October 2016